Skip Navigation


International Immunology Advance Access originally published online on March 29, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
16/5/635    most recent
dxh065v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Li Pira, G.
Right arrow Articles by Manca, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li Pira, G.
Right arrow Articles by Manca, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 16, No. 5, pp. 635-642, May 2004
© 2004 Japanese Society for Immunology

Identification of new Th peptides from the cytomegalovirus protein pp65 to design a peptide library for generation of CD4 T cell lines for cellular immunoreconstitution

Giuseppina Li Pira1, Laura Bottone3, Federico Ivaldi1, Roberta Pelizzoli2, Francesco Del Galdo4, Luisa Lozzi5, Luisa Bracci5, Arianna Loregian6, Giorgio Palù6, Raffaele De Palma4, Hermann Einsele7 and Fabrizio Manca1

1 Laboratory of Clinical and Experimental Immunology, G. Gaslini Institute, Genoa 16147, Italy 2 Viral Immunology Unit, Advanced Biotechnology Center, Genoa 16132, Italy 3 Department of Clinical and Biological Sciences, University of Insubria, Varese 21100, Italy 4 Department of Internal Medicine, II University of Naples, Naples 80125, Italy 5 Department of Molecular Biology, University of Siena, Siena 53100, Italy 6 Department of Histology, Microbiology and Medical Biotechnologies, University of Padua, Padua 35121, Italy 7 Department of Hematology-Oncology, Eberhard-Karls University, Tubingen D-72076, Germany

Correspondence to: F. Manca; E-mail: manca{at}cba.unige.it
Transmitting editor: L. Moretta

CD8 and CD4 lymphocytes control cytomegalovirus (CMV) infection in immunocompetent individuals, while patients with defective cellular immunity are prone to endogenous reactivation of latent CMV or, like seronegative subjects, prone to primary infection. Administration of CMV-specific CD8 lymphocytes was beneficial for immunocompromised hemopoietic stem cell (HSC) graft recipients. Since CD4 cells contribute to expansion of cytotoxic T lymphocytes (CTL), we defined new Th peptides on the immunodominant protein pp65 recognized by CD4 cells from HLA-typed subjects, in the perspective of complementing CTL administration with CMV-specific Th cells. Screening by ELISPOT on CD4 and CD8 subsets using overlapping peptides identified 10 novel CD4 peptides. To simplify procedures to generate T cell lines, we used a CD4 peptide library for T cell stimulation instead of ill-defined viral lysates, without the requirement of dendritic cells. This library stimulated CMV-specific CD4 cells. In fact, peptide-induced CD4 cells responded to pp65 and to the viral lysate. These cells were also devoid of alloreactivity after one stimulation cycle. Since Good Manufacturing Procedure-grade peptides can be synthesized, culture conditions are simplified and alloreactivity is rapidly lost, these procedures based on peptide stimulation can facilitate implementation of adoptive reconstitution of CD4 responses in immunocompromised patients also in the case when the HSC allodonor is available for generation of the T cell line.

Keywords: allodepletion, CD4 cell line, cellular immunotherapy, Th epitope


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CVIHome page
G. Li Pira, F. Ivaldi, C. Dentone, E. Righi, V. Del Bono, C. Viscoli, G. Koopman, and F. Manca
Evaluation of Antigen-Specific T-Cell Responses with a Miniaturized and Automated Method
Clin. Vaccine Immunol., December 1, 2008; 15(12): 1811 - 1818.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. M. M. van Leeuwen, E. B. M. Remmerswaal, M. H. M. Heemskerk, I. J. M. ten Berge, and R. A. W. van Lier
Strong selection of virus-specific cytotoxic CD4+ T-cell clones during primary human cytomegalovirus infection
Blood, November 1, 2006; 108(9): 3121 - 3127.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.